We found that treatment of MM cell lines with Hsp90 inhibitors [radicicol or 17-allylaminogeldanamycin (17AAG)] results in a significant upregulation of MICA and MICB expression, rendering these cells more efficient to activate NK cell degranulation [22]. This evidence concerns the gene MICB and Miyoshi myopathy.